For what it is worth (check my research for yourself), Cannvalate started out as a group of ambitious doctors who wanted to progress the MedCan industry and joined in at the primary production end.
They have followed what they believe is where the big money is at..... IP.
So imo Cannvalate probably needs IHL more than the other way round, but IHL now has access to the expertise of a group that have been at this for a lot longer than management have. Dr Sud has a lot of boxes to tick on his list, so while it may feel like he is the driver, that list of requirements when he signed on is what is the key driver of this companies direction.
Plenty of work to go, but gee it does look compelling.
IHL Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
